Hemotune
Edit

Hemotune

https://www.hemotune.ch/
Last activity: 26.03.2024
Active
Categories: DevelopmentDrugHardwareITMedTechTechnology
hemotune develops a revolutionary medical device for blood purification to provide the means to treat critically ill patients and save lives.
Mentions
39
Total raised: $28.74M

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
26.03.2024-$15.56M-
26.04.2022-$7.57M-
12.08.2020Series A$5.61M-

Mentions in press and media 39

DateTitleDescription
26.03.2024Hemotune secures CHF 14 Million in Series B2 Funding to advance innovative blood purification technologyHemotune secures CHF 14 Million in Series B2 Funding to advance innovative blood purification technology 26.03.2024 11:00, Rita Longobardi linkedIn facebook twitter instagram youtube --> Hemotune, a leading Swiss biotech firm renowned fo...
26.03.2024Hemotune secures CHF 14 Million in Series B2 Funding to advance innovative blood purification technologyThe Series B2 funding round represents a significant step forward for hemotune, following the successful completion of preclinical development for its HemoSystem blood purification platform. This substantial investment will now allow the pl...
25.03.2024CHF 14 million to fund hemotune’s clinical trials The HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads, stands out for its ability to effectively remove large biomolecules directly from patients' bloodstreams, offering a unique approach to impl...
28.04.2023Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million
24.03.2023AstraZeneca enters close collaboration with hemotune
15.11.2022Swiss startups get global exposure
27.10.2022hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood With Its Blood Purification PlatformHemoSystem improves patient outcomes while shortening the length of stay in intensive care units, reducing the sepsis burden for patients, hospitals, and healthcare systems. SAN ANTONIO, Oct. 27, 2022 /PRNewswire/ -- Recently, Frost & S...
17.06.2022Innovative technologies for Europe lie in Switzerland
26.04.2022hemotune raises CHF 7.25 million Series B1 funding for the development of their disruptive blood purification platformThe Series B1 will allow hemotune to complete the preclinical development of HemoSystem and prepare a clinical trial in hemotune’s lead indication. The HemoSystem is a blood purification platform with much higher efficiency and precision co...
26.04.2022CHF 7.25 million for a platform reducing the burden of sepsis
Show more

Reviews 0

Sign up to leave a review

Sign up Log In